Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Advanz, Alzinova, Arcadia, Arcutis, Avobis, Cellectar, Cosmo, EG 427, Kashiv, Lexeo, Neurizon, Orca Bio, Precision Neuromed, Spruce.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bridge to Life, Tosoh, Vektor.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bioarctic, Dyne, Evofem, Kexing, Medipal, Taho.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Icecure, Roche.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Aavantgarde, Aminex, BMS, Calico, Nacuity, Prothena, Taysha Gene Therapies.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Curonix, Hologic, Kardium.
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Bristol Myers Squibb, Cour, Cyprium, Ensem, Evofem, Fortress, Novartis, Pharma 1, Pharming, Sentynl, Taho.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Distalmotion, Karl Storz.